Dermato-pharmacokinetic study of single application of lanoconazole
Not Applicable
- Conditions
- healthy volunteer
- Registration Number
- JPRN-UMIN000029240
- Lead Sponsor
- Oita University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
*any skin abnormality *any drug, cosmetics, or food allergy *any abnormal findings in the following items, hematology, biochemistry, urinalysis, blood pressure, ECG, and clinical examination
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of lanoconazole in dermatological applications?
How does lanoconazole compare to standard antifungal treatments in terms of efficacy and safety?
Are there specific biomarkers associated with lanoconazole's dermato-pharmacokinetic profile?
What adverse events are commonly reported with lanoconazole use and how are they managed?
What are the potential combination therapies involving lanoconazole for dermatological conditions?